Mitchell P.; and Visner, Marc S., "Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs" (1992 We used a load-insensitive index of systolic left ventricular (LV) function and an analysis of diastolic pressure-dimension relationships to test the hypothesis that recombinant human (rh) tumor necrosis factor-a (TNFa) impairs LV function in dogs. Animals were studied 7-10 d after aseptic implantation of instrumentation to monitor cardiac output, external anteriorposterior LV diameter, and LV and pleural pressures. Data were analyzed from seven dogs that received active rhTNFa (100 Mg/kg over 60 min) and from five dogs that received heatinactivated rhTNFa. At 24 h after infusion of active rhTNFa, the slope of the LV end-diastolic dimension-stroke work relationship decreased significantly, indicating a decrement in LV systolic contractility. Simultaneously, LV unstressed dimension increased significantly, suggesting diastolic myocardial creep. The end-diastolic relationship between LV transmural pressure and normalized LV dimension (strain) was markedly displaced to the left, suggesting increased diastolic elastic stiffness. Despite these changes in LV performance, cardiac index was maintained by tachycardia. The abnormalities in LV function were resolved by 72 h. We conclude that rhTNFa reversibly impairs LV systolic and diastolic function in unanesthetized dogs. Because dysfunction occurs > 6 h after the infusion of rhTNFa and persists for 24-48 h, the mechanism underlying this phenomenon may involve secondary mediators or a change in myocardial gene expression. (J. Clin. Invest. 1992. 90:389-398.)
Introduction
Recent clinical and experimental studies strongly support the hypothesis that tumor necrosis factor-a (TNFa)' is a mediator oforgan dysfunction and shock induced by sepsis and endotoxtDeceased. 1 . Abbreviations used in this paper: BEL, ventricular dimension at beginning ejection; CM, tissue microsphere count; CR, reference microsphere count; e, Lagrangian strain; EDL, ventricular dimension at end diastole; EEL, ventricular dimension at end ejection; %ES, fractional ejection shortening ofleft ventricular minor axis diameter; L, ventricular minor axis dimension; 4, unstressed ventricular dimension; Lw, x-intercept ofthe preload recruitable stroke-work relationship; LV, left emia. Elevated plasma levels of TNFa are present in patients with a variety of infectious diseases (1) , and plasma levels of TNFa correlate with morbidity and mortality due to meningicoccal meningitis (2) . Administration of lipopolysaccharide (LPS) to humans (3) or animals (4, 5) , and infusion of live bacteria in animals (6, 7) increases plasma levels of TNFa.
Administration ofTNFa to humans (8, 9) , mice ( 10, 11 ) , rats (12) (13) (14) (15) (16) , rabbits ( 17) , dogs (18) (19) (20) , and sheep (21, 22) elicits manifestations of sepsis and septic shock, including fever, hypotension, acidosis, leukopenia, histopathological evidence of organ injury, and death. In experimental animals, survival is improved when monoclonal (23) or polyclonal (24) antibodies against TNFa are administered before challenge with live Escherichia coli or LPS.
Studies in patients (25) (26) (27) (28) and experimental animals (29) (30) (31) (32) indicate that alterations in myocardial performance are characteristic of sepsis and septic shock. Both left ventricular (LV) systolic dysfunction (depressed ejection fraction) and diastolic dysfunction (decreased chamber compliance) have been documented. Recent data suggest that TNFa is one ofthe mediators of sepsis-induced cardiac dysfunction. Recombinant human (rh) TNFa induces myocardial depression in dogs (19) and guinea pigs (S. 0. Heard, M. W. Perkins, and M. P. Fink, personal communication) , and suppresses the positive inotropic effect of isoproteronol in cultured murine fetal heart cells (34) .
The purpose of the present study was to rigorously test the hypothesis that rhTNFa impairs LV systolic and diastolic function in chronically instrumented conscious dogs. Alterations in systolic LV function were assessed by analyzing changes in the preload recruitable stroke-work relationship. This relationship is a load-insensitive index ofsystolic myocardial function that relates increases in LV stroke work to increases in preload (end-diastolic volume or dimension) (35) . Changes in the diastolic properties of the left ventricle were assessed by analyzing diastolic transmural pressure-dimension and transmural pressure-strain relationships. A preliminary report of these data has been published (36) .
Methods
Surgical preparation. 22 adult mongrel dogs (20-33 kg) were anesthetized with thiopental sodium (25 mg/kg; Abbott Laboratories, North Chicago, IL) and maintained on 1% halothane (Halocarbon Laboratories, Inc., North Augusta, SC) and pancuronium bromide (0.05 mg/ ventricular; Msw, slope of the preload recruitable stroke-work relationship; PA, arterial pressure; PLV, left ventricular intracavitary pressure; PPL, intrapleural pressure; PRA, right atrial pressure; PT, left ventricular transmural pressure; Q, cardiac output indexed to body weight; QM, myocardial blood flow; QR, reference blood flow; rhTNFa, recombinant human tumor necrosis factor-a; SVRI, systemic vascular resistance index; SW, stroke work; TNFa, tumor necrosis factor-a. kg; Quad Pharmaceutical, Inc., Indianapolis, IN). All animals received intravenous cefazolin (500 mg; Eli Lilly & Co., Indianapolis, IN) preoperatively. A left thoracotomy was performed through the fifth intercostal space, and the pericardium was opened and suspended to expose the heart. A pair of ultrasonic dimension transducers (Physiologic Monitoring Systems Group, Durham, NC) were implanted on the LV epicardium adjacent to the anterior and posterior descending coronary arteries to measure the external LV anterior-posterior minor axis diameter (Fig. 1) (38) . Data analysis. The first derivative ofPLv (dP/dt) was calculated as a running five-point orthogonal polynomial approximation from the digital pressure waveform. Diastolic and ejection phases of the cardiac cycle were defined using interactive software. The beginning of diastolic filling was defined as the first zero crossing of the dP/dt waveform following peak negative dP/dt (39) . End diastole was defined as the upstroke of the R wave of the electrocardiogram (39) . Beginning ejection was defined as the point 10 ms after peak positive dP/dt (39) . End ejection was defined as the point 20 ms before peak negative dPI dt (39, 40) . Only data from the mid-to end-expiratory phase of the respiratory cycle were considered for analysis to each pressure were then computed. For the purpose of illustration, exponential forms were also fit to the relationship between end-diastolic PTM and end-diastolic raw dimension (L), again using nonlinear least squares regression: PTM = a (eOLe -e).
Determination of cardiac output and systemic vascular resistance:
Cardiac output indexed to body weight (CQ) was computed by dividing the mean pulmonary artery flow measurement by body weight. Systemic vascular resistance index (SVRI) was calculated as: SVRI = (PA PRA)/QAssay for plasma levels of 6-keto-PGFIa. Venous blood samples were collected into iced-glass tubes containing 100 jig ofindomethacin and 10.5 mg ofEDTA. Samples were then centrifuged ( 1,500 g) at 40C
for 15 min. The plasma was collected and stored in polypropylene tubes at -70'C until assayed. Details of the radioimmunoassay for 6-keto-PGFI. (stable hydrolysis product of prostacyclin) have been reported previously (37) . The lower limit of sensitivity for the assay is 30 pg/ml. All samples were run in a single assay to obviate interassay variability.
Determination of myocardial blood flow. Microspheres were agitated for 10 min before injection. 7-10 million spheres ( 15 Elm) were injected through the left atrial catheter and flushed with 10 ml of normal saline. A reference arterial blood sample was obtained from the aortic arch at a withdrawal rate of 13.8 ml/min beginning 5 s before injection and continuing for 90 s. Myocardial blood flow, indexed per gram oftissue (QM), was calculated as: QM = CM*QR/CR, where CM is the microsphere count in the tissue sample, CR is the number ofspheres in the blood reference sample, and QR is the withdrawal rate of the reference sample.
Statistical analysis. Statistical analyses were performed using commercially available software (SAS Institute, Inc., Cary, NC). For the analyses of myocardial function, the calculated parameters from ten cardiac cycles were averaged. Two-way analysis of variance (ANOVA) with repeated measures was used to compare parameters to their baseline values (at -24 h) over time (within groups) and to compare timematched parameters between groups (42). When statistically significant differences were identified by ANOVA for group effects or grouptime interactions, Tukey's studentized range test for multiple comparisons was used to compare means at individual time points (43) . When statistically significant differences within groups over time were observed by ANOVA, single degree of freedom F-tests were used to compare the means at each time with baseline. Bonferonni's correction was utilized to compensate for the increased risk of a type I error with multiple comparisons (44) . The null hypothesis was rejected for P < 0.05. Data are presented throughout the tables as means± 1 SD.
Results
Disposition ofexperimental animals (Table I) . Of the 22 dogs that underwent implantation of the instrumentation, six were excluded because of technical failures or infectious complications. Of the 16 dogs entered into the study, 10 received active rhTNFa and six received inactivated rhTNFa. Data from 12 of these 16 animals were analyzed; seven that had received active rhTNFa and five controls. Four of the five dogs that died had positive blood cultures and were excluded from the final data analysis. One of the five deaths (active rhTNFa group) occurred at 72 h, immediately after passage of the manometertipped catheter into the left ventricle. This death was attributed to an embolic event, and because blood cultures in this animal were negative at 0 and 48 h, data collected before death were analyzed.
Metabolic and respiratory parameters (Table II) . There were no significant differences between groups at baseline for these variables: temperature ( 101.9±0.7 vs. 102.0±0.60F for control and rhTNFa groups, respectively), arterial pH, Po2, Pco2, and bicarbonate. Controls had slightly higher blood lac- Left ventricularfunction (Table IV) . There were no significant differences between the two groups in the baseline indices of systolic myocardial contractile function (SW, %ES, or slope and intercept of the preload recruitable stroke-work relationship). LV stroke work, %ES, and the slope and x-intercept of the preload recruitable stroke-work relationship were stable in animals infused with heat-inactivated rhTNFa (Figs. 2 and 3) . At 3 and 6 h after the administration of active rhTNFa, there was no evidence of systolic myocardial dysfunction as assessed by analysis of SW and the slope and intercept of the preload recruitable stroke work relationship. Fractional ejection shortening was significantly smaller than in the controls at 3, 6, 24, 48, and 72 h.
At 24 h, both SW and %ES were decreased significantly from baseline. These changes were accompanied by a decrease in the slope and a rightward shift (increase in x-intercept) of the preload recruitable stroke-work relationship, so that at any given LV end-diastolic dimension, LV stroke work was significantly decreased (Fig. 3) . By 48 h, SW and the slope and intercept of the preload recruitable stroke-work relationship were not significantly different from baseline, although the x-intercept remained significantly different from the controls until 72 h.
The diastolic relationships between LV end-diastolic PTM and either LV end-diastolic dimension (Fig. 4) or normalized 392 Pagani et al. (Table IV) . On the basis of the increase in Lo, different at baseline between the control and active rhTNFa there was a significant leftward shift in the end-diastolic PrMgroups. Administration ofheat-inactivated rhTNFa had no efstrain relationship (Figs. 5 and 6), with significant differences fect on these relationships (Fig. 4) or on unstressed LV dimenfrom the controls evident at 24 and 48 h. The leftward shift of sion (Table IV) . the end-diastolic Prm-strain relationship is consistent with a Administration of active rhTNFa elicited significant decrease in LV chamber compliance. By 72 h, the end-diastolic changes in the diastolic relationships of the left ventricle that Prm-strain relationship returned to baseline (Figs. 5 and 6).
were initially manifested 24 h after infusion of the cytokine.
Myocardial blood flow (Table V) . There were no signifiThese changes were characterized by a rightward shift of the cant differences in baseline subepicardial or subendocardial LV end-diastolic Pm--dimension relationship (Fig. 4) and an QM between control and active rhTNFa groups. After the ad- A hyperdynamic circulatory state with concomitant depression of myocardial function similar to that observed in this study has been described in studies of sepsis and septic shock (24, 26-31 ). Thus, our data suggest that rhTNFa is capable of eliciting the pattern of hemodynamic derangements and myocardial dysfunction characteristic of the sepsis syndrome. Our findings are therefore consistent with the hypothesis that TNFa is a mediator of some ofthe circulatory and cardiac manifestations of sepsis and septic shock. In the present study, systolic myocardial dysfunction was evidenced by a rightward shift and depression of the slope of the preload recruitable stroke work relationship, so that at any given LV preload (end-diastolic dimension), there was a significant reduction in the analogue of LV stroke work. The reduction in stroke work was due to both a decrease in fractional shortening of the minor axis dimension during the ejection phase of systole, and a decrease in peak systolic LV pressure. Myocardial depression was sufficient to decrease ejection shortening despite a concomitant reduction in SVRI (a proxy for LV afterload) and maintenance of baseline levels of preload (end-diastolic PTM and EDL). Fractional ejection shortening was depressed at 3 and 6 h, possibly owing to either increases in afterload, decreases in preload, or decreases in contractility that were not detectable in our model. Systolic myocardial dysfunction at 24 h also was evidenced by a significant reduction in the maximal rate of rise of LV pressure during isovolumic systole (dP/dt). This parameter is sensitive to loading conditions, however, and may have been influenced by the decrease in peak systolic PTM.
The most important finding of this study was the observation that infusion of rhTNFa caused significant diastolic dysfunction ofthe left ventricle characterized by these features: (a) [46] [47] [48] ), by slippage and realignment of the fibers (orderly rearrangement ofthe interstitial matrix [48, 49] ), and by disruption of the interstitial matrix (48, 50) . Although elongation ofsarcomere length and slippage between fiber layers probably occurs during ventricular expansion related to physiologic increases in preload, the elongation of dimension at a fixed stress (zero) suggests a change in fiber length or fiber arrangement that is not immediately reversible by physiologic restoring forces. In the case of rhTNFa-induced diastolic dysfunction, it is unknown whether elongation of unstressed dimension represents injury to the myocardial fibers and contractile proteins or disruption ofthe interstitial matrix. In the setting of reversible contractile dysfunction associated with myocardial stunning, extensive damage to the interstitial matrix has been demonstrated (50 Whether TNFa-induced myocardial injury is primarily to myocytes or to the interstitial matrix, the intermediate mechanisms underlying this injury remain unknown. Both direct effects ofTNFa on the myocardium or effects by secondary mediators seem plausible. It is unlikely that myocardial depression in our study was the result of rhTNFa-induced systemic metabolic abnormalities. At the time of maximum myocardial depression (24 h), animals were only mildly acidemic (pH 7.31±0.03). It is unlikely that this level ofacidosis can account for the observed degree of systolic dysfunction myocardial depression, since at 6 h, when systemic acidosis was more severe, there was no evidence of myocardial depression. Ventricular dysfunction also cannot be attributed to changes in subendocardial or subepicardial blood flow. Both systolic and diastolic dysfunction were evident at 48 h, when QM was not significantly less than baseline.
Myocardial injury induced by TNFa may depend upon the recruitment and activation of neutrophils. This hypothesis is consistent with these findings: (a) TNFa enhances margination and infiltration of neutrophils through endothelium (52, 53); (b) TNFa promotes adhesion of neutrophils to cardiac myocytes (54); and (c) neutrophils participate in ischemic myocardial injuries that result in both cell death and reversible contractile dysfunction (55) (56) (57) (58) (59) (60) . There is also evidence that TNFa promotes systemic and local release ofsecondary mediators from white blood cells (61-65) that could potentially compromise myocardial contractile function (66) (67) (68) (69) (70) . The finding in this study that the onset of ventricular dysfunction occurs 6-24 h after administration of rhTNFa, could be explained by neutrophil activation and subsequent infiltration into the myocardium with systemic and local release of mediators over a period of several hours.
Recent in vitro studies have described a direct effect of TNFa on the sympathomimetic stimulation of myocardial contractile function. Myocytes exposed to TNFa for 72 h demonstrate a decrease in isoproterenol-stimulated augmentation of contractile activity and production of cAMP (34) . These effects occur without a change in the density or affinity of fiadrenergic receptors. The response to forskolin, an inhibitor of adenylate cyclase, is not affected by exposure to TNFa (34) . These data suggest that myocardial cells express receptors for TNFa, which when activated, elicit derangements in the ,B receptor-regulatory GTP binding protein-adenylate cyclase transduction system ( 71 ).
Effects ofrhTNFa on hemodynamics, prostacyclin release, and arterial oxygenation. Consistent with previous reports by others (22) , we observed a marked increase in circulating levels of6-keto-PGFia after infusion ofrhTNFa. We measured levels of this prostanoid as an internal check to document that the cytokine was indeed active. Also consistent with previously published results (21, 22) was our observation that infusion of rhTNFa elicited fever and arterial hypoxemia, and decreased SVRI during the early (3-24 h) period after infusion.
Critique of experimental methods. The assessment of systolic and diastolic myocardial function in this study relied upon the analysis of a single external ventricular dimension (anterior-posterior axis diameter). Changes in this linear dimension have been substituted for changes in LV volume. Systolic stroke work is a pressure-volume integral rather than a pressure-dimension integral, and a more complete description of LV chamber compliance requires analysis of the diastolic pressure-volume relationship, rather than a pressure-diameter relationship. However, Rankin et al. (72) have demonstrated in a similar experimental preparation that changes in the anterior-posterior minor axis dimension during the cardiac cycle are highly correlated with changes in LV volume. We have validated under baseline conditions that changes in minor axis dimension during the ejection phase are highly correlated with changes in stroke volume, measured independently with the pulmonary artery flow probe used in this study (F. D. Pagani, unpublished observations).
The present study leaves some uncertainty in the time of onset of mechanical dysfunction of the left ventricle. Because no data were collected between 6 h and 24 h, the true onset of LV dysfunction may have occurred between these two time 396 points. Latent LV contractile dysfunction at earlier time points may have been masked by adrenergic stimulation. Furthermore, the statistical power of this study was limited by the availability of only a seven-animal X five-animal matrix of data for final analysis.
Finally, rather than obtaining tissue from ventricles for histologic and biochemical analysis at the time of their maximal dysfunction (24-48 h), we elected to document the reversibility of ventricular dysfunction and the time course of recovery. Future studies in which tissue is harvested 24-48 h after the administration of rhTNFa will therefore be necessary to elucidate the histologic and biochemical substrates of the myocardial injury.
